| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-112 |
Sentence |
denotes |
Xp21/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy. |
| TextSentencer_T2 |
113-222 |
Sentence |
denotes |
Clinically manifesting carriers of Duchenne muscular dystrophy (DMD) are rare among the pediatric population. |
| TextSentencer_T3 |
223-504 |
Sentence |
denotes |
A standardized diagnostic procedure in supposed DMD carriers entails performing a Multiplex Ligation-dependent Probe Amplification analysis of the DMD gene first, then taking a muscle biopsy to confirm reduced dystrophin levels and/or finally a complete sequencing of the DMD gene. |
| TextSentencer_T4 |
505-588 |
Sentence |
denotes |
We describe a girl with high-elevated creatine kinase, myalgia, and cardiomyopathy. |
| TextSentencer_T5 |
589-674 |
Sentence |
denotes |
Muscle biopsy showed a dystrophic pattern and nearly absent expression of dystrophin. |
| TextSentencer_T6 |
675-740 |
Sentence |
denotes |
Diagnosis could not be confirmed by molecular genetic procedures. |
| TextSentencer_T7 |
741-980 |
Sentence |
denotes |
Because of a mild mental retardation, a chromosome analysis and molecular karyotyping were performed, revealing a balanced translocation t(X;4)(p21;q31).arr(1-22,X)x2 dn with breakpoint on the X-chromosome within an intron of the DMD gene. |
| TextSentencer_T8 |
981-1178 |
Sentence |
denotes |
The inactivation of the nonderivative X-chromosome was found to be in a nonrandom pattern, resulting in a functionally balanced karyotype and thus leading to a manifesting DMD carrier in this case. |
| TextSentencer_T9 |
1179-1312 |
Sentence |
denotes |
Chromosome analysis should be recommended in cases of genetically unsolved DMD carriers as a part of the standard genetic procedures. |
| T1 |
0-112 |
Sentence |
denotes |
Xp21/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy. |
| T2 |
113-222 |
Sentence |
denotes |
Clinically manifesting carriers of Duchenne muscular dystrophy (DMD) are rare among the pediatric population. |
| T3 |
223-504 |
Sentence |
denotes |
A standardized diagnostic procedure in supposed DMD carriers entails performing a Multiplex Ligation-dependent Probe Amplification analysis of the DMD gene first, then taking a muscle biopsy to confirm reduced dystrophin levels and/or finally a complete sequencing of the DMD gene. |
| T4 |
505-588 |
Sentence |
denotes |
We describe a girl with high-elevated creatine kinase, myalgia, and cardiomyopathy. |
| T5 |
589-674 |
Sentence |
denotes |
Muscle biopsy showed a dystrophic pattern and nearly absent expression of dystrophin. |
| T6 |
675-740 |
Sentence |
denotes |
Diagnosis could not be confirmed by molecular genetic procedures. |
| T7 |
741-980 |
Sentence |
denotes |
Because of a mild mental retardation, a chromosome analysis and molecular karyotyping were performed, revealing a balanced translocation t(X;4)(p21;q31).arr(1-22,X)x2 dn with breakpoint on the X-chromosome within an intron of the DMD gene. |
| T8 |
981-1178 |
Sentence |
denotes |
The inactivation of the nonderivative X-chromosome was found to be in a nonrandom pattern, resulting in a functionally balanced karyotype and thus leading to a manifesting DMD carrier in this case. |
| T9 |
1179-1312 |
Sentence |
denotes |
Chromosome analysis should be recommended in cases of genetically unsolved DMD carriers as a part of the standard genetic procedures. |